Stoughton, MA, United States of America

Laising Yen

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Children's Medical Center Corporation. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laising Yen. Retrieved from https://idiyas.com/inventor/laising-yen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laising Yen: Innovator in Ribozyme Technology

Introduction

Laising Yen is a notable inventor based in Stoughton, MA (US). He has made significant contributions to the field of gene regulation through his innovative work on ribozymes. His research focuses on developing systems that can function effectively in mammalian cells.

Latest Patents

Laising Yen holds a patent for "Self-cleaving ribozymes and uses thereof." This patent describes compositions and methods related to a ribozyme-based gene regulation system. Specifically, it addresses schistosome self-cleaving RNA mutant motifs, showcasing the potential for advanced applications in genetic research.

Career Highlights

Yen is associated with the Children's Medical Center Corporation, where he applies his expertise in molecular biology and genetics. His work has implications for therapeutic developments and understanding gene expression mechanisms.

Collaborations

One of his notable collaborators is Richard C. Mulligan, with whom he has worked on various projects related to ribozyme technology.

Conclusion

Laising Yen's contributions to ribozyme technology and gene regulation highlight his role as an innovative inventor in the field. His work continues to pave the way for advancements in genetic research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…